Centro de Pesquisas em Biologia Molecular e Funcional, Instituto Nacional de Ciência e Tecnologia em Tuberculose, Escola de Ciências da Saúde e da Vida, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.
Programa de Pós-Graduação em Medicina e Ciências da Saúde, Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2388207. doi: 10.1080/14756366.2024.2388207. Epub 2024 Aug 14.
The crystallographic structure of the FolB enzyme from (FolB), complexed with its inhibitor 8-mercaptoguanine (8-MG), was elucidated at a resolution of 1.95 Å. A novel series of S8-functionalized 8-MG derivatives were synthesised and evaluated as inhibitors of dihydroneopterin aldolase (DHNA, EC 4.1.2.25) activity of FolB. These compounds exhibited IC values in the submicromolar range. Evaluation of the activity for five compounds indicated their inhibition mode and inhibition constants. Molecular docking analyses were performed to determine the enzyme-inhibitor intermolecular interactions and ligand conformations upon complex formation. The inhibitory activities of all compounds against the H37Rv strain were evaluated. Compound exhibited a minimum inhibitory concentration in the micromolar range. Finally, Compound showed no apparent toxicity in both HepG2 and Vero cells. The findings presented herein will advance the quest for novel, specific inhibitors targeting FolB, an attractive molecular target for TB drug development.
从 (FolB)中阐明了 FolB 酶与抑制剂 8-巯基鸟嘌呤(8-MG)形成的复合物的晶体结构,分辨率为 1.95Å。还合成了一系列新型的 S8 功能化 8-MG 衍生物,并将其评估为 FolB 的二氢蝶啶醛缩酶(DHNA,EC 4.1.2.25)活性的抑制剂。这些化合物表现出亚微摩尔范围内的 IC 值。对五种化合物的活性评估表明了它们的抑制模式和抑制常数。进行了分子对接分析,以确定酶-抑制剂相互作用和配体在形成复合物时的构象。评估了所有化合物对 H37Rv 菌株的活性。化合物 表现出微摩尔范围内的最小抑制浓度。最后,化合物 在 HepG2 和 Vero 细胞中均无明显毒性。本文的研究结果将推动针对 FolB 的新型、特异性抑制剂的研究,FolB 是结核病药物开发的一个有吸引力的分子靶标。